Genomic Prediction, Inc. — Form D
Genomic Prediction, Inc. of NORTH BRUNSWICK, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2021-12-15. The offering totals $12.0M, of which $12.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-12-15
- Form: D
- Accession: 0001897345-21-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $12.0M
- Remaining: $12
- Investors: 20
- Date of first sale: 2021-11-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-425134
Issuer
- Name: Genomic Prediction, Inc.
- CIK: 0001897345
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 675 US HIGHWAY ONE, NORTH BRUNSWICK, NJ, 08902
- Phone: (646) 954-7144
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Stephen Hsu | Director | Northville, MI |
| Nathan Mee | Director | Sutton, MA |
| Sailesh Ramakrishnan | Director | Los Altos, CA |
| Laurent Tellier | Director | North Brunswick, NJ |
| Stephen Hsu | Executive Officer | Northville, MI |
| Laurent Tellier | Executive Officer | North Brunswick, NJ |
More